Obstructive sleep apnea: What does the cardiovascular physician need to know?

American Journal of Cardiovascular Drugs

Volumn 5, Issue 2, 2005, Pages 71-81

  Collop, Nancy A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GLUCOSE INTOLERANCE; HEART INFARCTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PHYSICIAN ATTITUDE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; STROKE; SYMPTOMATOLOGY; TRACHEOTOMY; TRAFFIC ACCIDENT; UVULOPALATOPHARYNGOPLASTY; WEIGHT REDUCTION;

CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; HUMANS; PHYSICIANS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 14944365635     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200505020-00001     Document Type: Review

References (134)

1. Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-39
2. Bixler E, Vgontzas A, Lin H, et al. Prevalence of sleep-disordered breathing in women. Am J Respir Crit Care Med 2001; 163: 608-13
3. Redline S, Tishler P, Hans M, et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997; 155: 186-92
4. Kripke D, Ancoli-Israel S, Klauber M, et al. Prevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep 1997; 20 (1): 65-76
5. Young T, Shahar E, Nieto F, et al. Predictors of sleep-disordered breathing in community dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002; 162: 893-900
6. Bixler E, Vgontzas A, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157 (1): 144-8
7. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-89
8. Hoffstein V, Weiser W, Haney R. Roentgenographic dimensions of the upper airway in snoring patients with and without obstructive sleep apnea. Chest 1991; 100: 81-5
9. Haponik E, Smith P, Bohlman M, et al. Computerized tomography in obstructive sleep apnea. Am Rev Respir Dis 1983; 127: 221-6
10. Abbey N, Block A, Green D, et al. Measurement of pharyngeal volume by digitized magnetic resonance imaging: effect of nasal CPAP. Am Rev Respir Dis 1989; 40 (3): 717-23
11. Hoffstein V, Zamel N, Phillipson E. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis 1984; 130: 175-8
12. Mezzanotte W, Tangel D, White D. Waking genioglossus electromyogram in sleep apnea patients vs normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571-9
13. Van de Graaff W. Thoracic traction on the trachea: mechanisms and magnitude. J Appl Physiol 1991; 70: 1328-36
14. Larrson H, Carlson-Nordlander B, Lindblad L, et al. Temperature thresholds in the oropharynx of patient with obstructive sleep apnea syndrome. Am Rev Respir Dis 1992; 146: 1246-9
15. Kimoff R, Sforza E, Champagne V, et al. Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164: 250-5
16. Wasicko M, Hutt D, Parisi R, et al. The role of vascular tone in the control of upper airway collapsibility. Am Rev Respir Dis 1990; 141: 1569-77
17. Younes M, Ostrowski M, Thompson W, et al. Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2001; 163: 1181-90
18. Zwillich C, Devlin T, White D, et al. Bradycardia during sleep apnea: characteristics and mechanism. J Clin Invest 1982; 69: 1286-92
19. Schafer H, Hasper E, Ewig S, et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998; 12 (3): 679-84
20. Tilkain A, Guilleminault C, Schroeder J, et al. Hemodynamics in sleep induced apnea: studies during wakefulness and sleep. Ann Intern Med 1976; 85: 714-9
21. Guilleminault C, Motta J, Mihm F, et al. Obstructive sleep apnea and cardiac index. Chest 1986; 89: 331-4
22. Garpestad E, Katayama H, et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol 1992; 73 (5): 1743-8
23. Hedner J, Ejnell H, Sellgren J, et al. Is high and fluctuating muscle nervous system activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 1988; 6 Suppl. 4: S529-31
24. Somers V, Dyken M, Clary M, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904
25. Netzer N, Werner P, Jochums I, et al. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998; 29 (1): 87-93
26. Jenum P, Borgesen S. Intracranial pressure and obstructive sleep apnea. Chest 1989; 95: 279-83
27. Loeppky J, Voyles W, Eldridge M. Sleep apnea and autonomic cerebrovascular dysfunction. Sleep 1987; 10: 25-34
28. Shiomi T, Guilleminault C, Stoohs R, et al. Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. Chest 1991; 100: 894-902
29. Buda A, Pinsky M, Ingels N, et al. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 1979; 310: 453-9
30. Gleeson K, Zwillich C, White D. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 1990; 142: 295-300
31. Brooks L, Strohl K. Size and mechanical properties of the pharynx in healthy men and women. Am Rev Respir Dis 1992; 146: 1394-7
32. Mohsenin V. Gender differences in the expression of sleep-disordered breathing. Chest 2001; 120: 1442-7
33. Whittle A, Marshall I, Mortimore I, et al. Neck and soft tissue and fat distribution: comparison between normal men and women by magnetic resonance imaging. Thorax 1999; 54: 323-8
34. Popovic R, White D. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol 1998; 84 (3): 1055-62
35. Pillar G, Malhotra A, Fogel R, et al. Airway mechanics and ventilation in response to resistive loading during sleep: influence of gender. Am J Respir Crit Care Med 2000; 162: 1627-3
36. O'Connor C, Thornley S, Hanly P. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 145-72
37. Ware J, McBrayer R, Scott J. Influence of sex and age on duration and frequency of sleep apnea events. Sleep 2000; 23: 165-70
38. Peppard P, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3105-21
39. Davies R, Ali N, Stradling J. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47: 101-5
40. Fleetham JA. Upper airway imaging in relation to obstructive sleep apnea. Clin Chest Med 1992; 13: 399-416
41. Johns F, Strollo P, Buckley M, et al. The influence of craniofacial structure on obstructive sleep apnea in young adults. J Oral Maxillofac Surg 1998; 56: 596-602
42. Nelson S, Hans M. Contribution of craniofacial risk factors in increasing apneic activity among obese and nonobese habitual snorers. Chest 1997; 111: 154-62
43. Rappai M, Collop N, Kemp S, et al. The nose and sleep-disordered breathing: what we know and what we don't know. Chest 2003; 124 (6): 2309-23
44. Schellenberg J, Maislin G, Schwab R. Physical findings and the risk for OSA: the importance of oropharyngeal structures. Am J Respir Crit Care Med 2000; 162: 740-8
45. Guilleminault C, Stoohs R, Kim Y, et al. Sleep-related upper airway disordered breathing in women. Ann Intern Med 1995; 122: 493-501
46. Gottlieb D, Whitney C, Bonekat W, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999; 159 (2): 502-7
47. Johns M. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14 (6): 540-5
48. Lavie P, Yosef B, Rubin A. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108: 373-6
49. Kales A, Bixler E, Cadieux R, et al. Sleep apnea in a hypertensive population. Lancet 1984; II: 1005-8
50. Fletcher E, DeBehnke R, Lovoi M, et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190-5
51. Logan A, Perlikowski S, Mente A, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19: 2271-7
52. Nieto F, Young T, Lind B, et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community based study. JAMA 2000; 283: 1829-36
53. Peppard P, Yong T, Palta M, et al. Population based study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84
54. Lavie P, Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001; 24 (6): 721-5
55. Fletcher E, Miller J, Schaaf J, et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10: 35-44
56. Dimsdale J, Coy T, Ziegler M, et al. The effects of sleep apnea on plasma and urinary catecholamines. Sleep 1995; 18: 377-81
57. Carlson J, Rangemark C, Hedner J. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996; 14: 577-84
58. Narkiewicz K, Masahiko K, Phillips B, et al. Nocturnal CPAP decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100: 2332-5
59. Imodojemu V, Gleeson K, Quraishi S, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with CPAP therapy. Am J Respir Crit Care Med 2002; 165: 950-3
60. Phillips B, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000; 279: H234-7
61. Shek E, Brands M, Hall J. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-14
62. Becker H, Jerrentrup A, Ploch T, et al. Effect of nasal CPAP treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73
63. Kreiger J, Sforza E, Apprill M, et al. Pulmonary hypertension, hypoxemia and hypercapnia in obstructive sleep apnea patients. Chest 1989; 96: 729-37
64. Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients. Chest 1996; 109: 380-6
65. Sajkov D, Cowie R, Thornton A, et al. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994; 149: 416-22
66. Fletcher E, Schaaf J, Miller J, et al. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 1987; 135: 525-33
67. Chauout A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive lung disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151: 82-6
68. Kessler R, Chaouat A, Weitzenblum E, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996; 9: 787-94
69. Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 2000; 248: 13-20
70. Punjabi N, Sorkin J, Katzel L, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82
71. Ip M, Lam B, Mg M, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6
72. Spiegal K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9
73. Vgontzas A, Papanicolaou D, Bixler E, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151-8
74. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997; 241: 11-8
75. Vgontzas A, Bixler E, Chrousos G. Metabolic disturbances on obesity vs sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32-44
76. Brooks B, Cistulli P, Borkman M, et al. Obstructive sleep apnoea in obese noninsulin-dependent diabetic patients: effect of CPAP treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79: 1681-5
77. Smurra M, Philip P, Taillard J, et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apnoeic patients. Sleep Med 2001; 2: 207-13
78. Hung J, Whiford E, Parsons R, et al. Association of sleep apnea with myocardial infarction in men. Lancet 1990; 336: 261-4
79. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary disease. Am J Med 1996 Sep; 101 (3): 251-6
80. Shabar E, Whitney C, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001 Jan; 163: 19-25
81. Shamsuzzaman A, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4
82. Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94 (1): 179-84
83. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-9
84. Guilleminault C, Connolly S, Winkle R. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-4
85. Becker H, Koehler U, Stammnitz A, et al. Heart block in patients with sleep apnea. Thorax 1998; 53 Suppl. 3: S29-32
86. Tilkian A, Guilleminault C, Schroeder J, et al. Sleep-induced apnea syndrome: prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977 Sep; 63 (3): 348-58
87. Grimm W, Hoffman J, Menz V, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patient with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77: 1310-4
88. Becker H, Brandenburg U, Peter J, et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal CPAP. Am J Respir Crit Care Med 1995; 151: 215-8
89. Javaheri S, Parker T, Wexler L, et al. Occult sleep disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122 (7): 487-92
90. Wilcox I, McNamara S, Willson G, et al. Is sleep apnea a new prognostic marker in heart failure? Circulation 1995; 92: I-274
91. Sin D, Logan A, Fitzgerald F, et al. Effects of CPAP on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-6
92. Bassetti C, Aldrich M, Chervin R, et al. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology 1996; 47: 1167-73
93. Dyken M, Somers V, Yamada T, et al. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27: 410-7
94. Good D, Henkle J, Gelber D, et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27: 252-9
95. Barbe F, Pericas J, Munoz A, et al. Automobile accidents in patients with sleep apnea syndrome. Am J Respir Crit Care Med 1998; 158: 18-22
96. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents: Cooperative Group Burgos-Santander. N Engl J Med 1999; 340: 847-51
97. George C. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001; 56: 508-12
98. American Thoracic Society. Sleep apnea, sleepiness and driving risk. Am J Respir Crit Care Med 1994; 150: 1463-73
99. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159-65
100. He J, Keyger MH, Worick FJ, et al. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94: 9-14
101. Partinen M, Jamieson A, Guillmeminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 1988; 94: 1200-4
102. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-6
103. Flemons WW, Littner MR, Rowley JA, et al. Home diagnosis of sleep apnea: a systematic review of the literature. An evidence review co-sponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003; 124 (4): 1543-79
104. Engleman H, Martin S, Douglas N. Compliance with CPAP therapy in patients with the sleep apnea/hypopnea syndrome. Thorax 1994; 49: 263-6
105. Reeves-Hoche M, Meck R, Swillich C, et al. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149-54
106. Engleman H, Asgari-Jirhandeh N, McLeod A, et al. Self reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470-6
107. Hoffstein V, Viner S, Mateika S, et al. Treatment of obstructive sleep apnea with nasal CPAP: patient compliance, perception of benefits and side effects. Am Rev Respir Dis 1992; 145: 841-5
108. Kreiger J. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996; 19 (9 Suppl.): 136-43
109. Meurice J, Dore P, Paquesteau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994; 105: 429-33
110. Kaneko Y, Floras J, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-41
111. Chervin R, Theut S, Bassetti C, et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep 1997; 20: 284-9
112. Likar L, Panciera T, Erickson A, et al. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111: 1273-7
113. Jones D, Braid G, Wedzicha J. Nasal masks for domiciliary positive pressure ventilation: patient usage and complications. Thorax 1994; 49: 811-2
114. Richards G, Cistulli P, Ungar R, et al. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154: 182-6
115. Scharf M, Brannen D, McDannold M, et al. Computerized adjustable vs fixed NCPAP treatment of obstructive sleep apnea. Sleep 1996; 19: 491-6
116. Stradling J, Barbour C, Pitson D, et al. Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes. Thorax 1997; 52: 72-5
117. Meurice J, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996; 153: 794-8
118. Reeves-Hoche M, Hudgel D, Meck R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 443-9
119. Piper A, Sullivan C. Effect of short-term NIPPV in the treatment of patients with severe obstructive sleep apnea and hypercapnia. Chest 1994; 105: 434-40
120. Laursen S, Dreijer B, Hemmingsen C, et al. Bi-level positive airway pressure treatment of obstructive sleep apnoea. syndrome. Respiration 1998; 65: 114-9
121. Schafer H, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998; 92: 208-15
122. Shepard J, Olsen D. Uvulopalatopharyngoplasty for treatment of OSA. Mayo Clin Proc 1990; 65: 1260-7
123. Sasse S, Mahutte C, Kickeo M, et al. The characteristics of five patients with obstructive sleep apnea whose apnea-hypopnea index deteriorated after uvulopalatopharyngoplasty. Sleep Breath 2002; 6 (2): 77-83
124. Waite P, Wooten V, Lachner J, et al. Maxillomandibular advancement surgery in 23 patients with obstructive sleep apnea syndrome. J Oral Maxillofac Surg 1989; 47: 1256-61
125. Riley R, Powell N, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg 1993; 108: 117-25
126. Schmidt-Nowara W, Lowe A, Wiegand L, et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18: 501-10
127. Engleman H, McDonald J, Graham D, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: CPAP and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166: 855-9
128. Browman C, Sampson M, Yolles S, et al. Obstructive sleep apnea and body weight. Chest 1984; 85: 435-6
129. Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103: 850-5
130. Noseda A, Kempenaers C, Kerkhofs M, et al. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Chest 1996; 109: 138-43
131. Lojander J, Mustajoki P, Ronka S, et al. A nurse-managed weight reduction programme for obstructive sleep apnoea syndrome. J Intern Med 1998; 244: 251-5
132. Rasheid S, Banasiak M, Gallagher SF, et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003 Feb; 13 (1): 58-61
133. Jokic R, Klimaszewski A, Crossley M, et al. Positional treatment vs CPAP in patient with positional obstructive sleep apnea syndrome. Chest 1999; 115: 771-81
134. Craig T, Teets S, Lehman E, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998; 101: 633-7